As Cipla Battles Roche, Chairman Calls For India National Patent Pool To Lower Drug Prices
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Cipla Chairman Yusuf Hamied - known for his stance against patenting highly priced drugs - has appealed for the creation of a national patent pool, rather than an international patent pool, to combat neglected diseases like HIV, tuberculosis, malaria and diseases prevalent in the developing world